Ovarian Cancer Genetic Testing: Why, When, How?

Size: px
Start display at page:

Download "Ovarian Cancer Genetic Testing: Why, When, How?"

Transcription

1 Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine

2 Ovarian cancer Risk factors Age Nulliparity Personal history of breast or colon cancer Family history of ovarian cancer BRCA1 or BRCA2 carrier Lynch syndrome (HNPCC) Other single gene mutations (rare)

3 Family History of Ovarian Cancer Lifetime Risk None 1.5% 1 first-degree relative 3-5% 2 first-degree relatives 7% Hereditary ovarian cancer syndrome 40% Known BRCA1 or BRCA2 mutation 15-40%

4 Inherited Cancer Earlier age of onset Higher rate of bilaterality Associated tumors Not distinguished by pathology, metastatic pattern or survival characteristics

5 Why do genetic testing for hereditary cancer syndromes? For carrier, positive status will impact surveillance recommendations For non-carriers in families with mutation, avoids unnecessary interventions Risk-reducing surgery Family members impacted Reproductive decision-making

6 When is testing done? With new diagnosis, before surgery (breast cancer cases) With known mutation in family With suspicious family history Testing in asymptomatic patient at age when surveillance should begin (usually after age 21)

7 Causes of Hereditary Susceptibility to Ovarian Cancer BRCA1 ~70% 5% 10% Other genes ~8% HNPCC BRCA2 ~2% ~20%

8 Patients with > 25% chance of being in HBOC family Personal hx of both breast and ovarian cancer Have ovarian cancer AND close relative with ovarian cancer (any age) or breast cancer (<50) Jewish women with ovarian cancer (any age) or breast cancer (<40) Have breast cancer (<50) and close relative with ovarian cancer (any age) or male with breast ca 1 or 2 relative with known BRCA1 or BRCA2 mutation SGO Committee Statement, 2007

9 Determining risk of carrying BRCA1 or BRCA2 mutation Accessed at myriadtests.com

10 Lynch (HNPCC) syndrome Cancers in colon, endometrial, small bowel, ovary, biliary, ureter, brain Lifetime cancer risk 90% (any type) Highest risk is CRC-usually right-sided: 70-85% in men, 30-50% in women Endometrial CA risk 40-60% Ovarian cancer risk 10-15%

11 Interpretation of genetic test results Normal no significant gene change identified Pathogenic (or Likely pathogenic) gene change causes disease Benign (or Likely benign) gene change does NOT causee disease Variant of undetermined significance (VUS) cannot classify risk

12 Variant of Uncertain Significance (VUS) A sequence within a gene not typically found in the general population and not consistently associated with disease VUS are found in approximately 12% of women tested for BRCA1/2 status 1 ; higher in other genes VUS should be discussed with all individuals considering cancer genetic testing 2 1. Domchek et al. J Clin Oncol Miller Samuel et al. Semin Oncol 2011

13 Drawbacks of genetic testing Will results make a difference in my care? May be inconclusive Risk for developing cancer not always established What interventions are available?

14 Management of BRCA1/BRCA2 mutation carriers Intervention Recommendation Screening Breast self exam Monthly, starting at age 18 Clinical breast exam Q 6 months, starting age 25 Mammogram Yearly, start at age 25* Breast MRI Yearly, start at age 25* Pelvic exam Q 6 12 months, start age 25 TV sono and CA 125 # Q 6 months, start 10 yr earlier than ovarian ca onset in family Chemoprevention Tamoxifen Case by case basis, mutation specific? Oral contraceptives Case by case basis Prophylactic surgery Mastectomy RRSO Case by case At age 35 40, after childbearing Based on NCCN guidelines, 2011

15 Ovarian Cancer: Risk Reduction Birth control pills 5 years of use: 27% reduction 15 years of use: 60% reduction First full-term pregnancy < age 25; number of pregnancies Breast-feeding BTL/hysterectomy RR 0.33/0.67 Prophylactic oophorectomy Risk of primary peritoneal cancer remains

16 Multi gene panels Caveats Selection of genes Accuracy of results Detection rates of mutations within the genes Rate of uncertain variants

17 Northwestern Cancer Genetics Program Ovarian cancer gene testing BRCA1, BRCA2 Lynch syndrome genes: MLH1, MSH2, MSH6, PMS2 RAD51C RAD51D BRIP1 TP53

18 New indications for BRCA testing BRCA deficient tumors demonstrate increased sensitivity to poly(adp ribose)polymerase inhibitors ( PARP inhibitors ) PARP inhibitors being investigated as followup therapy in patients with recurrent tumors, especially with initial favorable response to platinum based treatment

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer

patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer What is hereditary cancer? Cancer affects many people in the U.S.: breast cancer affects 1 in 8 women and ovarian

More information

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide What is Hereditary? Breast cancer is the most common cancer in women in the U.S. (it affects about 1 in 8 women). Ovarian

More information

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary

More information

Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010

Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 Advice about familial aspects of breast cancer and epithelial ovarian cancer a guide for health professionals DECEMBER 2010 This guide has three parts: 1. Information for health professionals 2. Tables

More information

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

ScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015

ScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015 ScreenWise Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015 ScreenWise Three programs working together to bring quality screening services to Oregon residents Why we all do this work

More information

if your family has a history

if your family has a history if your family has a history OF CANCER. put it to the test. Learn about your risk for hereditary and ovarian and how you can reduce it. do you have a family history of Breast or Ovarian Cancer? what does

More information

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013 Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your

More information

Understanding Your Risk of Ovarian Cancer

Understanding Your Risk of Ovarian Cancer Understanding Your Risk of Ovarian Cancer A WOMAN S GUIDE This brochure is made possible through partnership support from Project Hope for Ovarian Cancer Research and Education. Project HOPE FOR OVARIAN

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t

More information

Office of Population Health Genomics

Office of Population Health Genomics Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation

More information

Hereditary Breast Cancer Testing. Diagnostic

Hereditary Breast Cancer Testing. Diagnostic Hereditary Cancer Testing Diagnostic New solutions for hereditary breast cancer. Identifying and understanding the genetic contribution to breast cancer allows for individualized disease management and

More information

Prevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC)

Prevention GENEration. The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC) הסיכוי שבסיכון PREVENTION GENERATION Prevention GENEration The Importance of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome (HBOC) We thank Prof. Ephrat Levy-Lahad Director, Medical

More information

GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP

GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT

More information

BRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS

BRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 Breast cancer is the most common cancer in women, diagnosed in

More information

Gynecologic Cancer in Women with Lynch Syndrome

Gynecologic Cancer in Women with Lynch Syndrome Gynecologic Cancer in Women with Lynch Syndrome Sarah E. Ferguson, MD FRCSC Division of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto June 11, 2013 Objective 1. To review the

More information

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,

More information

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall

More information

Breast cancer and genetics

Breast cancer and genetics Breast cancer and genetics Cancer and genes Our bodies are made up of millions of cells. Each cell contains a complete set of genes. We have thousands of genes. We each inherit two copies of most genes,

More information

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet

BRCA Genes and Inherited Breast and Ovarian Cancer. Patient information leaflet BRCA Genes and Inherited Breast and Ovarian Cancer Patient information leaflet This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could

More information

Progress and Prospects in Ovarian Cancer Screening and Prevention

Progress and Prospects in Ovarian Cancer Screening and Prevention Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian

More information

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations

More information

INTERVENTIONS BREAST CANCER GENETICS YOUNG BREAST CANCER SURVIVORS

INTERVENTIONS BREAST CANCER GENETICS YOUNG BREAST CANCER SURVIVORS INTERVENTIONS BREAST CANCER GENETICS YOUNG BREAST CANCER SURVIVORS AND THEIR AT-RISK RELATIVES Maria C. Katapodi, PhD, RN, FAAN Professor of Nursing Faculty of Medicine, University of Basel, Switzerland

More information

Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org

Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org Breast Cancer s Link to Ovarian Cancer: It s in Your Genes foundationforwomenscancer.org There are now more than 2.6 million women in America who have been diagnosed with breast cancer. A very small fraction

More information

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service Understanding Hereditary Breast and Ovarian Cancer Maritime Hereditary Cancer Service General Information Cancer is very common. About one in three (33%) people are diagnosed with some form of cancer during

More information

The Department of Vermont Health Access Medical Policy

The Department of Vermont Health Access Medical Policy State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department

More information

Risk Assessment and Screening Tools November 17, 2010

Risk Assessment and Screening Tools November 17, 2010 Risk Assessment and Screening Tools November 17, 2010 Cecelia Bellcross Posted in the Resource Repository at: http://www.resourcerepository.org/documents/2073/riskassessmentandscreeningtool s/ Cecelia

More information

HEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk?

HEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk? HEREDITARY BREAST CANCER BRCA1 Faulty gene INFORMATION LEAFLET How Do I Reduce My Risk? Page 1 CONTENTS Part A 1 What is BRCA1 2 How does BRCA1 affect a person s risk of cancer? 3Testing for BRCA1 4Benefits

More information

BRCA1 & BRCA2 GeneHealth UK

BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 3 people developing cancer at some point in their lifetime. Breast cancer occurs

More information

Patient Support Guide

Patient Support Guide Patient Support Guide to genetic testing for hereditary breast and ovarian cancer syndrome Testing for BRCA1 and BRCA2 is available from Quest Diagnostics. Quest Diagnostics Patient Support Guide to Genetic

More information

Are You at Risk for Ovarian Cancer?

Are You at Risk for Ovarian Cancer? Are You at Risk for Ovarian Cancer? A Woman s Guide Read this brochure to learn more about ovarian cancer symptoms, risk factors and what you can do to reduce your risk. ALL WOMEN HAVE SOME RISK OF OVARIAN

More information

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

If you are still in your fertility years If you are past your fertility years and need surgery for a mass or for pain and have normal ovaries

If you are still in your fertility years If you are past your fertility years and need surgery for a mass or for pain and have normal ovaries If you are still in your fertility years, an ovary should be removed only if there is a large, complex or persistent mass on it or if you have intolerable pain from endometriosis. There should be an attempt

More information

Understanding Lynch Syndrome

Understanding Lynch Syndrome ESSENTIALS Lynch Syndrome Understanding Lynch Syndrome Certain cancers can run in families. Sometimes this happens because of harmful changes (called mutations) in our genes that are passed from one generation

More information

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group

Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection

More information

Hereditary Breast and Ovarian Cancer (HBOC)

Hereditary Breast and Ovarian Cancer (HBOC) Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Hereditary Breast and Ovarian Cancer (HBOC) Information for women with an increased lifetime risk of breast and ovarian cancer What

More information

Lesson Plan: Genetic Testing and Hereditary Cancer

Lesson Plan: Genetic Testing and Hereditary Cancer Lesson Plan: Genetic Testing and Hereditary Cancer OVERVIEW This lesson plan is designed to be used with the film In the Family, which explores issues related to genetic testing and the difficult decisions

More information

Name of Policy: Genetic Testing for Hereditary Breast and/or Ovarian Cancer

Name of Policy: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Name of Policy: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Policy #: 513 Latest Review Date: January 2014 Category: Laboratory Policy Grade: B Background/Definitions: As a general rule,

More information

What s In Your Genes: How changes in the BRCA1/BRCA2 genes

What s In Your Genes: How changes in the BRCA1/BRCA2 genes ESSENTIALS BRCA1/BRCA2 Mutations What s In Your Genes: How changes in the BRCA1/BRCA2 genes might affect you and your family Our genes contain the codes for producing the proteins that are the building

More information

Beyond BRCA the Future is Now

Beyond BRCA the Future is Now Beyond BRCA the Future is Now Richard P. Frieder, MD Medical Director, Intelegene Assistant Clinical Professor Department of Obstetrics and Gynecology David Geffen School of Medicine, UCLA University of

More information

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt

More information

Recommendations for the management of early breast cancer

Recommendations for the management of early breast cancer Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation FEBRUARY 2014 Incorporates published evidence to August

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

Number 12.04.516 Effective Date August 11, 2015 Revision Date(s) Replaces 2.04.133 (not adopted)

Number 12.04.516 Effective Date August 11, 2015 Revision Date(s) Replaces 2.04.133 (not adopted) MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDI HISTORY Genetic Testing for CHEK2 Mutations for Breast Cancer Number 12.04.516

More information

Genetic Testing for CHEK2 Mutations for Breast Cancer

Genetic Testing for CHEK2 Mutations for Breast Cancer Genetic Testing for CHEK2 Mutations for Breast Cancer Policy Number: 2.04.133 Last Review: 8/2015 Origination: 8/2015 Next Review: 8/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic

More information

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or

More information

Cancer Screening and Early Detection Guidelines

Cancer Screening and Early Detection Guidelines Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical

More information

Genetic Counseling and Testing: Cancer Genetics

Genetic Counseling and Testing: Cancer Genetics KAISER PERMANENTE HAWAII CLINICAL PRACTICE GUIDELINE Genetic Counseling and Testing: Cancer Genetics QUALITY COMMITTEE ADOPTION DATE: October 2015 LAST REVIEW DATE: September 2015 NEXT SCHEDULED REVIEW

More information

Draft Benefit Coverage Standard for Genetic Testing Recommendations

Draft Benefit Coverage Standard for Genetic Testing Recommendations Draft Benefit Coverage Standard for Genetic Testing Recommendations Colorado Medicaid Benefits Collaborative Meeting: February 12, 2015 Authored by: Devki S. Saraiya, MS, CGC, Licensed Genetic Counselor

More information

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: GENETIC TESTING FOR, 10/15/15 PAGE: 1 OF: 12 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Breast Cancer Follow-Up

Breast Cancer Follow-Up Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Breast Cancer Follow-Up Breast Cancer Follow-Up Version 2002: Thomssen / Scharl Version 2003 2009: Bauerfeind / Bischoff /

More information

Genetic Services Policy Project

Genetic Services Policy Project Hereditary Breast and Ovarian Cancer: A Policy Brief What are Hereditary Breast and Ovarian Cancers (HBOC)? HBOCs are cancers associated with autosomal dominant genetic mutations with reduced penetrance.

More information

Genetic/Familial High-Risk Assessment: Breast and Ovarian

Genetic/Familial High-Risk Assessment: Breast and Ovarian NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Genetic/Familial High-Risk Assessment: Version 2.2015 NCCN.org Continue Version 2.2015, 06/25/15 National Comprehensive Cancer Network,

More information

BREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1

BREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1 Hello, my name is Rachel Jankowitz, I m an assistant professor of medicine in the Division of Hematology Oncology at the University of Pittsburgh

More information

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening. CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests

More information

Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome)

Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome) Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer

Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer NIKKI BREHENY, ELIZABETH GEELHOED, JACK GOLDBLATT & PETER O LEARY Abstract Aim: To examine the relative cost-effectiveness

More information

Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine Practice Policy Statement

Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine Practice Policy Statement ATTENTION This Policy was reaffirmed by the ACPM Board of Regents on 1/31/2005 and is effective through 1/31/2010. Screening Asymptomatic Women for Ovarian Cancer: American College of Preventive Medicine

More information

Ovarian Cancer 101 Jessica McAlpine, MD

Ovarian Cancer 101 Jessica McAlpine, MD Ovarian Cancer 101 Jessica McAlpine, MD Different types of ovarian cancer: Outline: Ovarian Cancer Presentation, behavior, site of origin Primary treatment: surgery, chemo, +/-radiation Role of genetics

More information

Breast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW

Breast Cancer Screening. Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Breast Cancer Screening Dr Jennifer Tan Radiologist Alfred Imaging BreastScreen SLHD, SWSLHD and GWNSW Learning Objectives Identify risk factors for breast cancer What to do with this information - GP

More information

Breast cancer risk assessment: high risk

Breast cancer risk assessment: high risk Breast cancer risk assessment: high risk This leaflet is for women with a high risk of breast cancer (following a family history risk assessment). It gives information on how common breast cancer is, screening,

More information

Breast and Ovarian Cancer

Breast and Ovarian Cancer Breast and Ovarian Cancer Hereditary Breast and Ovarian Cancer A Guide for Clinicians KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS Hereditary Breast and Ovarian Cancer Panel

More information

Your Jewish Genes. Hereditary Breast Cancer and Ovarian Cancer

Your Jewish Genes. Hereditary Breast Cancer and Ovarian Cancer E D U C A T I O N A L B O O K L E T S E R I E S Your Jewish Genes Hereditary Breast Cancer and Ovarian Cancer 2011 Sharsheret, Inc. All rights reserved. 07/11 3000 Your Jewish Genes Hereditary Breast Cancer

More information

Oregon Survey Instrument

Oregon Survey Instrument Oregon Survey Instrument Cancer Genetic Insurance Questions for Insurers Q1a. Do you have written policies on your coverage of cancer genetic testing, counseling, and follow-up procedures for breast and

More information

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Familial Breast Cancer Referrals and Risk Management

Familial Breast Cancer Referrals and Risk Management Familial Breast Cancer Referrals and Risk Management Presented by: Helen Mountain Genetic Counsellor Genetic Services of WA Perth (KEMH and PMH) Joondalup Rockingham Bunbury Geraldton Kalgoorlie Albany

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): May 20, 2014 Effective Date: December 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

19. CANCER OF THE CORPUS UTERI

19. CANCER OF THE CORPUS UTERI 19. CANCER OF THE CORPUS UTERI 19.1. SUMMARY Cancer of the uterus is classified by ICD-10 into three sites cancer of the cervix uteri (cervical cancer; see Chapter 20), cancer of the corpus uteri (uterine

More information

Illinois Insurance Facts Illinois Department of Insurance

Illinois Insurance Facts Illinois Department of Insurance Illinois Insurance Facts Illinois Department of Insurance Women s Health Care Issues Revised August 2012 Note: This information was developed to provide consumers with general information and guidance

More information

Screening guidelines tool

Screening guidelines tool Screening guidelines tool Disclaimer: This material is intended as a general summary of screening and management recommendations; it is not intended to be comprehensive. Colorectal cancer (CRC) screening

More information

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer Contents Introduction: biology and medicine, two separated compartments What we need to know: - boring basics in DNA/RNA structure and overview of particular aspects of molecular biology techniques - How

More information

Breast Cancer Screening

Breast Cancer Screening Breast Cancer Screening Summary of the Clinical Practice Guideline September 2013 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate

More information

Breast cancer in the family

Breast cancer in the family Birmingham Women's NHS Foundation Trust Breast cancer in the family Information for women with a slightly increased risk of breast cancer This is a no smoking hospital Breast cancer in the family what

More information

Cancer: Genetic testing can save lives

Cancer: Genetic testing can save lives Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who

More information

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011 Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: May 2015 Policy No: 02 Effective Date:

More information

From www.gp update.co.uk one day courses for GPs, by GPs

From www.gp update.co.uk one day courses for GPs, by GPs Ovarian cancer Ovarian cancer is notoriously difficult to diagnose and is frequently diagnosed late. However, it is not a silent killer. How best can we work out when to suspect it and what investigations

More information

UNDERSTANDING OVARIAN CANCER DVD INSIDE. featuring. Shannon Miller. Olympic Gold Medalist and Cancer Survivor SGO

UNDERSTANDING OVARIAN CANCER DVD INSIDE. featuring. Shannon Miller. Olympic Gold Medalist and Cancer Survivor SGO UNDERSTANDING OVARIAN CANCER featuring Shannon Miller Olympic Gold Medalist and Cancer Survivor DVD INSIDE SGO Contents 3 Introduction 4 About Ovarian Cancer 6 Risk Factors for Ovarian Cancer 9 Symptoms

More information

Ovarian Cancer. What is cancer?

Ovarian Cancer. What is cancer? What is cancer? Ovarian Cancer The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly way. During the early years of a person's life,

More information

Breast Cancer in the Family

Breast Cancer in the Family Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family

More information

Hereditary Cancer Risk Assessment: Indicators of Hereditary and Familial Risk

Hereditary Cancer Risk Assessment: Indicators of Hereditary and Familial Risk Hereditary Cancer Risk Assessment: Indicators of Hereditary and Familial Risk Karen Copeland Certified Genetic Counselor Director International Medical Affairs Myriad Genetics GmbH Impact of Hereditary

More information

The iq&a interactive Medical Intelligence Zone BRCA Gene Testing

The iq&a interactive Medical Intelligence Zone BRCA Gene Testing The iq&a interactive Medical Intelligence Zone BRCA Gene Testing for Breast Cancer Focus on Guideline-Directed BRCA-1 and BRCA-2 Diagnostic Testing and Evidence-Based Management of Breast Cancer A Year

More information

Genetic Testing for Hereditary Breast/ Ovarian Cancer Syndrome (BRCA1/BRCA2)

Genetic Testing for Hereditary Breast/ Ovarian Cancer Syndrome (BRCA1/BRCA2) MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDIX HISTORY Genetic Testing for Hereditary Breast/ Ovarian Cancer Syndrome

More information

IMMEDIATE HOT LINE: Effective March 2, 2015

IMMEDIATE HOT LINE: Effective March 2, 2015 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

Genetic Testing for Cancer: What You Need to Know

Genetic Testing for Cancer: What You Need to Know Genetic Testing for Cancer: What You Need to Know Here is some basic information about genetic testing and how it s used to learn about inherited cancer risk. It will help you understand what genetic testing

More information

Cancer Facts for Women

Cancer Facts for Women 2006, American Cancer Society, Inc. No.200700-Rev.03/08 The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem

More information

Ovarian cancer. A guide for journalists on ovarian cancer and its treatment

Ovarian cancer. A guide for journalists on ovarian cancer and its treatment Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and

More information

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive WOOD COUNTY SCHOOL OF PRACTICAL NURSING Medical/Surgical Nursing: Reproductive Time: 19 Hours Theory; 1 Hour Pharmacology IV, (1 Diet Therapy - Integrated.) Placement: Nursing IV. Instructor: Toni Tennant,

More information

Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes

Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO 09/01/2011

More information

Surgical History (Please provide Month/Year for all that apply):

Surgical History (Please provide Month/Year for all that apply): DATE: Name: First MI Last Maiden Date of Birth: Reason for Visit: Primary Care Provider: Personal Medical History (PLEASE CHECK ALL THAT APPLY): Diabetes, Type 1 Seizures High Blood Pressure Migraine/Headaches

More information

Breast cancer in families. This booklet explains what a family history of breast cancer is, and what this may mean for you or your family.

Breast cancer in families. This booklet explains what a family history of breast cancer is, and what this may mean for you or your family. Breast cancer in families This booklet explains what a family history of breast cancer is, and what this may mean for you or your family. Worried Lorem about ipsum breast dolore cancer estes Contents

More information